Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 62 Carcinoma, Non-Small-Cell Lung 45 Triple Negative Breast Neoplasms 24 Ovarian Neoplasms 20 Fallopian Tube Neoplasms 17 Lung Neoplasms 16 Neoplasm Metastasis 15 Endometrial Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Stomach Neoplasms 12 Esophageal Neoplasms 10 Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Esophageal Squamous Cell Carcinoma 8 Colorectal Neoplasms 7 Inflammatory Breast Neoplasms 6 Head and Neck Neoplasms 6 Uterine Cervical Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Carcinoma 5 Melanoma 4 Carcinoma, Transitional Cell 4 Carcinoma, Squamous Cell 4 Adenocarcinoma Of Esophagus 4 Urinary Bladder Neoplasms 3 Peritoneal Neoplasms 3 Pancreatic Neoplasms 3 Oropharyngeal Neoplasms 3 Mouth Neoplasms 3 Lung Diseases 3

Interventions

Paclitaxel 1 Nivolumab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Pancoast Syndrome × Paclitaxel × Clear all

NCT05684276 2026-05-05

DUMAS

Fundación GECP

Phase 2 Active not recruiting

Pancoast Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡